title: Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis.
abstract: OBJECTIVE
  The incidence of irritable bowel syndrome (IBS) or functional bowel disorders (FBD) after bacillary dysentery (BD) has not been extensively evaluated, and little is known of the pathogenesis of post-infective (PI) IBS. Therefore, we investigated the incidence of IBS and FBD in a Chinese patient population who had recovered from BD. To further elucidate its pathogenesis, neuroimmunological changes, including interleukins (IL), mast cells, neuropeptides, and the relationship between mast cells and intestinal nerves, were investigated.
  
  
  METHODS
  A cohort study of 295 patients who had recovered from BD (shigella identified from stool in 71.4%) and 243 control subjects consisting of patient siblings or spouses who had not been infected with BD were included in the study. All subjects were followed up using questionnaires for 1-2 years to explore the incidence of FBD and IBS, as defined by the Rome II criteria. In 56 cases of IBS (PI and non-PI) from another source, the number of mast cells in biopsy specimens from the intestinal mucosa were stained with antitryptase antibody and counted under light microscopy. Also, the relationship of mast cells to neurone specific enolase (NSE), substance P (SP), 5-hydroxytryptamine (5-HT), or calcitonin gene related peptide positive nerve fibres was observed using double staining with alcian blue and neuropeptide antibodies. In 30 cases of IBS (PI-IBS, n = 15) taken at random from the 56 cases, expression of interleukin (IL)-1alpha, IL-1beta, and IL-1 receptor antagonist (IL-1ra) mRNAs in intestinal mucosa were identified using reverse transcription-polymerase chain reaction. The above results were compared with 12 non-IBS controls.
  
  
  RESULTS
  In the BD infected cohort, the incidences of FBD and IBS were 22.4% and 8.1% (in total)-10.2% (among those in who shigella were identified) respectively, which were significantly higher (p<0.01) than the incidences of FBD (7.4%) and IBS (0.8%) in the control cohort. A longer duration of diarrhoea (>or=7 days) was associated with a higher risk of developing FBD (odds ratio 3.49 (95% confidence interval 1.71-7.13)). Expression of IL-1beta mRNA in terminal ileum and rectosigmoid mucosa was significantly higher in PI-IBS patients (p<0.01). The number of mast cells in the terminal ileum mucosa in PI-IBS (11.19 (2.83)) and non-PI-IBS patients (10.78 (1.23)) was significantly increased compared with that (6.05 (0.51)) in control subjects (p<0.01). Also, in the terminal ileum and rectosigmoid mucosa of IBS patients, the density of NSE, SP, and 5-HT positively stained nerve fibres increased (p<0.05) and appeared in clusters, surrounding an increased number of mast cells (p<0.01 compared with controls).
  
  
  CONCLUSIONS
  BD is a causative factor in PI-IBS. The immune and nervous system may both play important roles in the pathogenesis of PI-IBS.
authors.affiliation: Department of Gastroenterology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
authors.forename: L-H
authors.initials: LH
authors.lastname: Wang
authors.forename: X-C
authors.initials: XC
authors.lastname: Fang
authors.forename: G-Z
authors.initials: GZ
authors.lastname: Pan
mesh_terms: D000328:Adult; D015740:Calcitonin Gene-Related Peptide / Q000032:analysis; D003109:Colonic Diseases, Functional / Q000209:etiology*; D003967:Diarrhea / Q000150:complications; D004405:Dysentery, Bacillary / Q000150:complications*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007375:Interleukin-1 / Q000032:analysis; D007413:Intestinal Mucosa / Q000737:chemistry; D043183:Irritable Bowel Syndrome / Q000209:etiology; D008297:Male; D008407:Mast Cells / Q000473:pathology; D009412:Nerve Fibers / Q000473:pathology; D010751:Phosphopyruvate Hydratase / Q000032:analysis; D012307:Risk Factors; D012701:Serotonin / Q000032:analysis; D013373:Substance P / Q000032:analysis
chemical_list: D007375:Interleukin-1; D012701:Serotonin; D013373:Substance P; D010751:Phosphopyruvate Hydratase; D015740:Calcitonin Gene-Related Peptide